Stocks

English support document including tables from the PR. Significant improvement in non-financial indicators, with major advances for employees, residents and patients Health and safety: decline in the work-related accident frequency rate, at 24.8 in 2023 (down 2 points vs. 2022 and down 8 points …

HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809;NASDAQ:EVO) today announced the appointment of Aurélie Dalbiez as the Company's new Chief People Officer ("CPO"), effective 15 June 2024. Aurélie will be joining Evotec's Management Board, bringing …

GOTHENBURG, Sweden, April 17, 2024 /PRNewswire/ -- "During Q1 2024, demand continued to normalize at good levels across many of the Volvo Group's markets. Adjusted for currency, net sales were on the same level as in Q1 2023 and amounted to SEK 131.2 billion. …

Tryg A/S Tryg’s Supervisory Board has today approved the Q1 2024 interim report. Tryg reported an insurance service result of DKK 1,275m (DKK 1,474m) and a combined ratio of 86.6 (84.0) in Q1 2024, adversely impacted by more than DKK 180m higher than normal …

Key Insights GlobalData's estimated fair value is UK£3.19 based on 2 Stage Free Cash Flow to Equity GlobalData's UK£1.93 share price signals that it might be 39% undervalued The UK£2.70 analyst price target for DATA is 15% less than our estimate of fair value …

Novartis Pharma AG Continuous Kesimpta® treatment for up to six years showed sustained efficacy in recently diagnosed (≤3 years) treatment-naïve people living with relapsing multiple sclerosis (RMS) in an analysis of the ALITHIOS open-label extension study1 Similar efficacy outcomes were demonstrated in a separate …

ASML Netherlands BV ASML reports €5.3 billion total net sales and €1.2 billion net income in Q1 2024 2024 outlook unchanged VELDHOVEN, the Netherlands, April 17, 2024 – Today, ASML Holding NV (ASML) has published its 2024 first-quarter results. Q1 total net sales of …